Highest Score

Ranked by analysis score
Ranks this page's recent reports by score.
Applied Materials, Inc.
AMAT·Technology
A ★★★★Buy
Current$507.18
Target$607.50
Return+19.8%
Aug 16, 2026

Applied Materials is a highly profitable supplier to AI and advanced computing, but export-control tensions and the sustainability of hyperscaler capex remain key risks to monitor.

Score
88
Coherent Corp.
COHR·Technology
A ★★★★Buy
Current$327.23
Target$462.35
Return+41.3%
Aug 15, 2026

Coherent's integrated photonics, U.S. manufacturing advantages and operating leverage position it for AI data center growth, but scaling 6-inch wafer facilities amid fierce global competition poses execution risks.

Score
88
Camtek Ltd.
CAMT·Technology
A ★★★★Buy
Current$174.20
Target$202.50
Return+16.2%
Aug 13, 2026

Camtek is the highly profitable, indispensable tollbooth for the global AI and HBM packaging supercycle, trading at a relative discount to its direct peers, though investors must vigilantly monitor the intense regulatory risks associated with its massive Chinese revenue exposure.

Score
88
Liquidia Corporation
LQDA·Healthcare
A ★★★★Buy
Current$79.79
Target$117.20
Return+46.9%
Aug 13, 2026

Liquidia is successfully leveraging its proprietary, highly precise PRINT technology to aggressively disrupt a multi-billion-dollar cardiopulmonary monopoly, driving explosive revenue growth and massive margin expansion, though investors must remain hyper-vigilant regarding the intense commercial and pricing retaliation from the incumbent legacy competitor.

Score
88
Simon Property Group, Inc.
SPG·Real Estate
A ★★★★Buy
Current$220.55
Target$245.12
Return+11.1%
Aug 13, 2026

Simon Property is the undisputed, cash-gushing apex predator of Class-A retail real estate, leveraging immense pricing power and brilliant capital recycling to fund high-yield densification, though investors must monitor the friction of a $28.7 billion debt load in a restrictive rate environment.

Score
88
Praxis Precision Medicines, Inc.
PRAX·Healthcare
A ★★★★Buy
Current$370.00
Target$615.00
Return+66.2%
Aug 13, 2026

Praxis is poised to monopolize a stagnant multi-billion dollar essential tremor market and a high-margin pediatric epilepsy market through first-in-class precision neurology, trading at an attractive forward valuation, though investors must remain hyper-vigilant regarding binary FDA approval decisions and the complexities of commercial payer negotiations.

Score
88
Henry Schein, Inc.
HSIC·Healthcare
A ★★★★Buy
Current$88.13
Target$97.15
Return+10.2%
Aug 12, 2026

Henry Schein combines dominant distribution scale with an accelerating, high-margin software and specialty product portfolio, offering a compelling long-term compounder at a reasonable valuation despite near-term macroeconomic and consolidation headwinds.

Score
88
American Financial Group, Inc.
AFG·Financials
A ★★★★Buy
Current$145.59
Target$173.00
Return+18.8%
Aug 11, 2026

American Financial Group is an elite, highly disciplined specialty insurer that utilizes its formidable pricing power and vast investment float to generate massive excess capital, aggressively returning value to shareholders through colossal special dividends while trading at a highly reasonable valuation.

Score
88
Vistra Corp.
VST·Utilities
A ★★★★Buy
Current$140.59
Target$205.92
Return+46.5%
Aug 10, 2026

Vistra's zero-carbon power assets serve AI data center demand at discounted forward multiples with strong buybacks, but federal intervention in capacity markets remains a threat.

Score
88
ITT Inc.
ITT·Industrials
A ★★★★Buy
Current$213.13
Target$260.00
Return+22.0%
Aug 9, 2026

ITT is transforming into a highly profitable industrial compounder through the accretive SPX FLOW acquisition and structural EV/aerospace tailwinds, though investors must monitor the execution risks tied to elevated post-merger leverage and cyclical auto exposure.

Score
88
Atmos Energy Corporation
ATO·Utilities
A ★★★★Buy
Current$170.19
Target$185.00
Return+8.7%
Aug 9, 2026

Atmos Energy offers a highly visible, low-risk earnings compounder anchored by its robust Texas pipeline network and consistent rate base expansion, making it a premium utility for stable income, provided regulatory relations remain constructive.

Score
88
Nutrien Ltd.
NTR·Materials
A ★★★★Buy
Current$64.42
Target$81.21
Return+26.1%
Aug 9, 2026

Nutrien leverages irreplaceable Tier-1 mining assets and a vast, high-margin retail network to generate enormous cash flows even at the bottom of the agricultural cycle, offering a cheap valuation and aggressive buybacks, provided investors can stomach the cyclical threat of incoming global potash supply.

Score
88